A 20-year-old woman experiencing sudden, severe hair loss seeks advice on diagnosis and treatment options. Suggestions include using minoxidil and spironolactone, consulting a dermatologist, and considering stress or health factors as potential causes.
A 28-year-old male experienced hair loss after COVID-19 and used Minoxidil with initial success, but later faced shedding again. He started Finasteride in February 2025, noticing improvements, but recent shedding has caused concern; his regimen includes Minoxidil, microneedling, ketoconazole shampoo, red light therapy, supplements, and a healthy lifestyle.
The user experienced significant hairshedding after 1.5 years on dutasteride and oral minoxidil, possibly due to a shedding cycle or lifestyle changes like nicotine use and creatine. Opinions vary on whether creatine contributes to hair loss, with some attributing shedding to synchronized hair cycles or genetic factors.
The user experienced a sudden decrease in hair density after starting alfatradiol while already using finasteride. Another user mentioned that initial shedding can occur with hair loss treatments, but it may not last long.
Hairshedding can be gradual and varies daily, with some noticing less shedding over time. Treatments like Minoxidil, finasteride, and RU58841 are not mentioned in this conversation.
This paper identifies challenges in diagnosing alopecia variants, emphasizing the importance of pathologists understanding hair follicle histology, biopsy types, and collaborating with dermatologists to improve diagnostic accuracy.
75 citations
,
October 1996 in “Dermatologic Clinics”
This review examines chronic telogen effluvium, highlighting its distinctive features and the need for reassurance about its non-progressive nature, but reports no new clinical results.